Hepatitis C Virus NS3, aa1192-1459, Recombinant (HCV)
Catalog No : USB-138017
571.28€
0.00€
Shipping cost plus VAT not included , delivery in 7-14 business days
Product name | Hepatitis C Virus NS3, aa1192-1459, Recombinant (HCV) | ||
---|---|---|---|
Catalog No | USB-138017 | ||
Supplier’s Catalog No | 138017 | ||
Supplier | US Biologicals | ||
Source antigen | Recombinant, E.coli | ||
Reactivity | |||
Cross reactivity | |||
Applications | |||
Molecular weight |
Storage | -20°C | ||
---|---|---|---|
Other names | |||
Grade | Highly Purified | ||
Purity | ~90% (SDS-PAGE) | ||
Form | Supplied as a liquid in 20mM Tris-HCl, pH 8.0, 20mM beta mercaptoethanol. | ||
Reactivity life | 6 months | ||
Note | For reserch purpose only | ||
Purity | ~90% (SDS-PAGE) | ||
Description | HCV is a small 50nm, enveloped, single-stranded, positive sense RNAvirus in the family Flaviviridae. HCV has a high rate of replication with approximately one trillion particles produced each day in an infected individual. Due to lack of proofreading by the HCV RNA polymerase, the HCV has an exceptionally high mutation rate, a factor that may help it elude the host's immune response. Hepatitis C virus is classified into six genotypes (1-6) with several subtypes within each genotype. The preponderance and distribution of HCV genotypes varies globally. Genotype is clinically important in determining potential response to interferon-based therapy and the required duration of such therapy. Genotypes 1 and 4 are less responsive to interferon-based treatment than are the other genotypes (2, 3, 5 and 6). Source: Recombinant protein corresponding to aa1192-1459 of HCV NS3 immunodominant regions of Hepatitis C Virus protein, expressed in E.coli. Applications: Suitable for use in ELISA and Western Blot. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 6 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. |
© 2020 Imugex All Rights Reserved